SCHEDULE 13G Filed 2026-11-06 Event — SEC 0000315066-26-002950 →

FMR LLC → ASPEN NEUROSCIENCE INC ASPE

Stake: — Shares: — Class: COMMON STOCK

Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 25/100

Disqualifiers: PIPE_OR_FINANCING_ARTIFACT: Uniform >=$10M structured financing block

Passive Schedule 13G filer baseline
2 independent officer/director Code-P buyers ($30,000,000 in ±30d)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

27 transactions

6 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

49 filings by this filer

48 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-11-02	ARCH Venture Fund X, L.P.	10%+ owner	Buy	66,666	$15.00	$1000K
2026-11-02	ARCH Venture Fund X, L.P.	10%+ owner	C	187,182	—	—
2026-11-02	ARCH Venture Fund X, L.P.	10%+ owner	C	298,258	—	—
2026-11-02	ARCH Venture Fund X, L.P.	10%+ owner	C	286,304	—	—
2026-11-02	ARCH Venture Fund X, L.P.	10%+ owner	C	295,490	—	—
2026-11-02	ARCH Venture Fund X, L.P.	10%+ owner	C	259,948	—	—
2026-11-02	ARCH Venture Fund X, L.P.	10%+ owner	Buy	66,667	$15.00	$1.00M
2026-11-02	ARCH Venture Fund X, L.P.	10%+ owner	C	214,355	—	—
2026-11-02	ARCH Venture Fund X, L.P.	10%+ owner	Buy	1,200,000	$15.00	$18.00M
2026-11-02	ARCH Venture Partners XIV, L.P.	10%+ owner	Buy	1,200,000	$15.00	$18.00M
2026-11-02	Spaventa Andrew	director	C	70,194	—	—
2026-11-02	Spaventa Andrew	director	C	180,221	—	—
2026-11-02	Hasnain Faheem	director, officer	C	14,913	—	—
2026-11-02	Hasnain Faheem	director, officer	C	14,316	—	—
2026-11-02	Hasnain Faheem	director, officer	C	7,120	—	—
2026-11-02	Thompson Peter A.	director, 10%+ owner	C	196,541	—	—
2026-11-02	Thompson Peter A.	director, 10%+ owner	C	642,745	—	—
2026-11-02	Thompson Peter A.	director, 10%+ owner	C	616,984	—	—
2026-11-02	Thompson Peter A.	director, 10%+ owner	C	625,743	—	—
2026-11-02	Thompson Peter A.	director, 10%+ owner	C	507,119	—	—
2026-11-02	Thompson Peter A.	director, 10%+ owner	Buy	1,000,000	$15.00	$15.00M
2026-11-02	ORBIMED ADVISORS LLC	director, 10%+ owner	C	196,541	—	—
2026-11-02	ORBIMED ADVISORS LLC	director, 10%+ owner	C	642,745	—	—
2026-11-02	ORBIMED ADVISORS LLC	director, 10%+ owner	C	616,984	—	—
2026-11-02	ORBIMED ADVISORS LLC	director, 10%+ owner	C	625,743	—	—

Showing 25 of 27

Other 13D/G Filings on ASPEN NEUROSCIENCE INC

Filed	Form	Filer	Stake	Shares
2026-11-06	SCHEDULE 13D	ORBIMED ADVISORS LLC	12.30%	3,589,132	view →
2026-11-06	SCHEDULE 13G	GILEAD SCIENCES, INC.	—	—	view →
2026-11-03	SCHEDULE 13G	Qatar Investment Authority	—	—	view →

Other Filings by FMR LLC

Filed	Form	Issuer	Stake	Shares
2026-11-06	SCHEDULE 13G	CITY THERAPEUTICS INC	—	—	view →
2026-11-06	SCHEDULE 13G	BYRNA TECHNOLOGIES INC	—	—	view →
2026-11-05	SCHEDULE 13G	ACCELEVATION HOLDINGS CORP	—	—	view →
2026-11-05	SCHEDULE 13G	AMER SPORTS INC	—	—	view →
2026-11-05	SCHEDULE 13G	BRAVEHEART BIO INC	—	—	view →
2026-10-07	SCHEDULE 13G	ILLUMINA INC	—	—	view →
2026-10-07	SCHEDULE 13G	SKYWORKS SOLUTIONS INC	—	—	view →
2026-09-08	SCHEDULE 13G	ADI GLOBAL DISTRIBUTION INC	—	—	view →
2026-09-08	SCHEDULE 13G	ONTERRIS INC	—	—	view →
2026-09-08	SCHEDULE 13G	AVANTIS RESPONSIBLE INTERNATIONAL EQUITY ETF	—	—	view →
2026-08-19	SCHEDULE 13D/A	Fidelity Multi-Strategy Credit Fund	52.20%	3,082,424.46	view →
2026-08-06	SCHEDULE 13G	ABERCROMBIE & FITCH CO	—	—	view →
2026-08-06	SCHEDULE 13G	BROWN & BROWN INC	—	—	view →
2026-08-06	SCHEDULE 13G	AXOS FINL INC	—	—	view →
2026-08-06	SCHEDULE 13G	ANTERIS TECHNOLOGIES GLOBAL CORP	—	—	view →
2026-08-06	SCHEDULE 13G	AMPLITUDE INC	—	—	view →
2026-08-06	SCHEDULE 13G	ALCOA CORP	—	—	view →
2026-08-06	SCHEDULE 13G	ADEIA INC	—	—	view →
2026-08-06	SCHEDULE 13G	AMERICAN PUBLIC EDUCATION INC	—	—	view →
2026-08-06	SCHEDULE 13G	ACI WORLDWIDE INC	—	—	view →

Showing 20 of 48

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →